Le Lézard
Classified in: Health, Business
Subject: PDT

Wellcare's Expanded 2024 Medicare Advantage and Medicare Prescription Drug Plan Offerings Bring Enhanced Value and Affordability to Members


Wellcare will offer 23 newly designed plans as well as new Dual Eligible Special Needs Plans, accepting all dual eligible beneficiaries

New in 2024, Wellcare Spendablestm debit card will allow pre-loaded funds to be used across 55,000 nationwide retailers in 37 states

Wellcare to offer Medicare Advantage plans to 37 states and 102 Prescription Drug Plans nationwide

TAMPA, Fla., Oct. 11, 2023 /PRNewswire/ -- Wellcare, the Medicare brand and wholly owned subsidiary of Centene Corporation (NYSE: CNC), announced today it will expand its wide range of Medicare Advantage (MA) and Medicare Prescription Drug Plan (PDP) offerings during the 2024 Medicare Annual Enrollment Period (AEP), beginning Oct. 15, 2023. This includes the addition of Delaware and expansion into 21 new counties, increasing its total Medicare Advantage footprint to 37 states and 1,808 counties. Wellcare will also now offer the 23 newly designed plans as well as new Dual Eligible Special Needs Plans (D-SNP), accepting all dual eligible beneficiaries, and introduce a Wellcare Spendablestm debit card that will allow pre-loaded funds to be used across 55,000 nationwide retailers in 37 states.

"Centene's Medicare footprint has grown in the past several years, and we are proud to continue offering Wellcare's Medicare Advantage products now in 37 states, including the newest state of Delaware," said Chief Executive Officer of Medicare for Centene, Rich Fisher, Wellcare's parent company. "We are committed to serving our communities, members, brokers and partners with exceptional healthcare solutions by offering a wide range of comprehensive products that support our members' whole health. The investments and innovations we've made like our Wellcare Spendable card will make things simpler and more affordable for our members."

Expanded Footprint and Plan Offerings
For 2024, Wellcare will be offering plans to more than 52 million eligible beneficiaries, accounting for 80% of eligible beneficiaries in 37 states. More than 1.5 million beneficiaries are currently enrolled in an Wellcare Medicare Advantage plan.

In addition to Delaware, Wellcare also added 21 new counties in four markets: California, Delaware, Pennsylvania and Washington. Wellcare will offer 23 newly designed plans as well as new D-SNP, accepting all dual eligible beneficiaries, even those who are not cost-share protected in Alabama; Arkansas; Florida; Georgia; Kentucky; Louisiana; Michigan; Mississippi; North Carolina; New Mexico; Ohio; Oklahoma; Texas and Wisconsin.

Wellcare's 2024 MA Plans:

Wellcare's MA New Strategic Partners:

2024 Medicare PDP Highlights:

The 2024 Medicare AEP begins on Oct. 15, and continues through Dec. 7, 2023. Most plans purchased during AEP are effective Jan. 1, 2024. For more details about Centene's MA and Medicare PDP, visit www.WellcareNow.com.

About Wellcare
For more than 20 years, Wellcare has offered a range of Medicare products, including Medicare Advantage and Medicare Prescription Drug Plans (PDP), which offer affordable coverage beyond Original Medicare. Today, the company offers benefits with every Medicare beneficiary in mind, such as dental, hearing and vision services; transportation services; telehealth visits; wellness and fitness programs; in-home support services; and special supplemental benefits for the chronically ill. Wellcare is a wholly owned subsidiary of Centene Corporation, a leading healthcare enterprise committed to transforming the health of the community, one person at a time. Beginning Jan. 1, 2022, Centene's Medicare brands, including Allwell, Health Net, Fidelis Care, Trillium Advantage, 'Ohana Health Plan and TexanPlus transitioned to the Wellcare brand. For more information about Wellcare, visit www.wellcare.com.

'Ohana Health Plan, a plan offered by WellCare Health Insurance of Arizona, Inc.

Wellcare is the Medicare brand for Centene Corporation, an HMO, PPO, PFFS, PDP plan with a Medicare contract and is an approved Part D Sponsor. Our D-SNP plans have a contract with the state Medicaid program. Enrollment in our plans depends on contract renewal.

Our plans use a formulary.

Washington residents: Health Net Life Insurance Company is contracted with Medicare for PPO plans. "Wellcare by Health Net" is issued by Health Net Life Insurance Company.

Washington residents: "Wellcare" is issued by Wellcare of Washington, Inc.

Washington residents: "Wellcare" is issued by WellCare Health Insurance Company of Washington, Inc.

"Wellcare" is issued by WellCare Prescription Insurance, Inc.

For Louisiana D-SNP members: As a Wellcare HMO D-SNP member, you have coverage from both Medicare and Medicaid. You receive your Medicare health care and prescription drug coverage through Wellcare and are also eligible to receive additional healthcare services and coverage through Louisiana Medicaid. Learn more about providers who participate in Louisiana Medicaid by visiting www.myplan.healthy.la.gov/en/find-provider or https://www.louisianahealthconnect.com. For detailed information about Louisiana Medicaid benefits, please visit the Medicaid website at https://ldh.la.gov/medicaid and select the "Learn about Medicaid Services" link. To request a written copy of our Medicaid Provider Directory, please contact us.

Notice: TennCare is not responsible for payment for these benefits, except for appropriate cost sharing amounts. TennCare is not responsible for guaranteeing the availability or quality of these benefits. Any benefits above and beyond traditional Medicare benefits are applicable to Wellcare Medicare Advantage only and do not indicate increased Medicaid benefits.

For Indiana D-SNP prospective enrollees: For detailed information about Indiana Medicaid benefits, please visit the Medicaid website at https://www.in.gov/medicaid/

Arizona D-SNP plans: Contract services are funded in part under contract with the State of Arizona.

New Mexico (NM) Dual Eligible Special Needs Plan (D-SNP) Members: As a Wellcare by Allwell D-SNP member, you have coverage from both Medicare and Medicaid. Medicaid services are funded in part by the state of New Mexico. NM Medicaid benefits may be limited to payment of Medicare premiums for some members.

Louisiana D-SNP prospective enrollees: For detailed information about Louisiana Medicaid benefits, please visit the Medicaid website at https://ldh.la.gov/medicaid or https://www.louisianahealthconnect.com. To request a written copy of our Medicaid Provider Directory, please contact us.

Wellcare by Allwell (HMO and HMO SNP) includes products that are underwritten by Superior HealthPlan, Inc. and Superior HealthPlan Community Solutions, Inc.

Wellcare (HMO and HMO SNP) includes products that are underwritten by WellCare of Texas, Inc., WellCare National Health Insurance Company, and SelectCare of Texas, Inc.

Please contact your plan for details.

Other Pharmacies/Physicians/Providers are available in our network.

SOURCE Wellcare


These press releases may also interest you

at 14:06
On Wednesday, May 15, Red Door Community hosted their annual Celebrating Women Working and Living with Cancer Luncheon at the Metropolitan Club in New York City. The event raised more than $300,000 while shining a light on the women who inspire us...

at 14:05
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 13:27
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

at 11:03
Boston Scientific Corporation today announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRMtm System,* the first modular cardiac rhythm management (CRM) system that consists of the EMBLEMtm Subcutaneous...

at 08:35
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

at 07:05
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: